A brief history of mumps and mumps treatments in the UK

What happens to virus whistleblowers after they blow the whistle?

Peptomyc and the quest to develop a 'universal' cancer treatment

Is pharma ready to tackle the health effects of continued climate change?

Inactive pharmaceutical ingredients can make problems worse for patients 

After the year of the mega-merger, will 2020 be the year of the pharma spin out?

Improving cancer treatment with precise, personalised targets

An inside look at the Signals Analytics drug development playbook

Turning attention towards patient benefits with IDMP data standards implementation